Valiant Laboratories logo

Valiant Laboratories results

NSE: VALIANTLABBSE: 543998Pharmaceuticals & BiotechnologySmall Cap

Last close ₹128.43down ₹2.62 (2.00%)BSE ₹129.25

Share price at the NSE close on 23 Oct 2026. Previous close ₹131.05.

52-week range of traded prices to 23 Oct 2026
₹49.51Low, 4 Mar 2026₹141.38High, 19 Oct 2026
Market cap
₹698 Cr2,048th largest listed
P/E
43.6
P/B
2.2
Dividend yield
Nonein the last 12 months
ROE
5.9%
ROCE
7.0%
Debt to equity
0.14
Volume, NSE
9,957

Q1 results, quarter to Jun 2026

Consolidated: the company and its subsidiaries together. ₹ crore.Valiant Laboratories annual results and balance sheet

Revenue
₹115 Cr+146.2% on a year ago · +25.3% on the quarter before
Operating profit
₹29 Cr+1,119.5% on a year ago · +507.8% on the quarter before
Net profit
₹21 Cr+1,058.9% on a year ago · +1,099.9% on the quarter before
Earnings per share
₹3.89+826.2% on a year ago · +1,115.6% on the quarter before
Operating margin
25.4%
Net margin
18.3%

From revenue to net profit, ₹ crore

  1. Revenue115
  2. Materials and goods−68
  3. Employee costs−2.6
  4. Other expenses−16
  5. Operating profit29
  6. Depreciation−2.9
  7. Other income+0.9
  8. Finance costs−1.1
  9. Profit before tax26
  10. Tax−5.1
  11. Net profit21

Valiant Laboratories results by quarter

Consolidated: the company and its subsidiaries together. Latest quarter to Jun 2026. Results for the quarter to Sep 2026 are due by 14 Nov 2026, 45 days after it ends.Results filings and date

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
  • Loss

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
₹ croreJun 2023worked outSep 2023Q2Filed 20 NovDec 2023Q3Filed 22 FebMar 2024Q4Filed 16 MayJun 2024Q1Filed 24 AugSep 2024Q2Filed 27 DecDec 2024Q3Filed 7 FebMar 2025Q4Filed 12 JunJun 2025Q1Filed 8 AugSep 2025Q2Filed 11 NovDec 2025Q3Filed 11 FebMar 2026Q4Filed 14 MayJun 2026Q1Filed 10 Aug
Revenue from operations516041311921355847465292115
48614735212835544446538786
Materials and goods bought42554130192129484040457268
Employee costs1111111111233
Other expenses454416554561216
Operating profit before depreciation4−1−6−5−2−71420−1529
Operating margin7.4%−2.3%−15.6%−14.8%−12.6%−31.4%1.8%6.6%5.1%0.2%−1.7%5.2%25.4%
Depreciation and amortisation0001111111233
Other income2323332−211101
Finance costs0000000000111
One-off items0000000000000
Profit before tax61−5−30−42120−3126
20−2−101−10104−15
Tax rate26.1%25.4%––––−44.9%25.1%25.6%27.6%–−68.0%19.4%
41−4−1−1−52120−7221
Other comprehensive income–000000000000
Total comprehensive income41−4−1−1−52120−7221
Net margin8.3%1.3%−8.6%−4.1%−2.7%−22.1%6.7%1.2%3.9%0.4%−13.5%1.9%18.3%
Earnings per share–₹0.24−₹0.81−₹0.33−₹0.12−₹1.09₹0.54₹0.16₹0.42₹0.04−₹1.30₹0.32₹3.89
Earnings per share in rupees, restated for later splits and bonuses.